+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inappropriate macrophage activation syndrome associated with visceral leishmaniasis in an infant

Inappropriate macrophage activation syndrome associated with visceral leishmaniasis in an infant

Tunisie Medicale 77(12): 648-650

A case of haemophagocytosis is reported in a 20-month-old boy presenting with fever, hepatosplenomegaly, pancytopenia and coagulopathy. An initial diagnosis of kala-azar was rejected because of absence of biological inflammatory syndrome and absence of leishmania in bone marrow. Specific serology for visceral leishmaniasis become positive after a week and he was treated with N-methylglucantime for 21 days.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 003473139

Download citation: RISBibTeXText

Related references

Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis. La Tunisie Medicale 77(12): 648-650, 2000

Visceral leishmaniasis leading to macrophage activation syndrome. Medecine et Maladies Infectieuses 2019, 2019

Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis. Archives de Pediatrie 22(4): 397-400, 2015

Severe macrophage activation syndrome following visceral leishmaniasis in a child. Medecine et Sante Tropicales 24(2): 221-223, 2015

Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient. Acta Medica Portuguesa 31(10): 593-596, 2018

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. Internal Medicine Journal 46(11): 1347-1348, 2016

Visceral leishmaniasis and bronchial asthma: influence of steroid therapy in the development of the macrophage activation syndrome and relative adrenal insufficiency. Anales de Medicina Interna 25(6): 279-283, 2009

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology 8: 181, 2018

Epstein-Barr virus infection and syndrome of inappropriate macrophage activation. Pediatrie 48(6): 459-462, 1993

Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response. Cytokine 113: 200-215, 2018

Syndrome of activation of the mononuclear phagocyte system. Initial manifestation of visceral leishmaniasis. Archives Francaises de Pediatrie 45(1): 45-46, 1988

Analysis of different macrophage population to study role of macrophage in generation of specific immune protection in visceral leishmaniasis. Indian Journal of Parasitology 14(2): 129-133, 1990

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Joint, Bone, Spine 77(3): 271-273, 2010

Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations. International Journal of Dermatology 46(12): 1326, 2008

Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). International Journal of Dermatology 48(1): 59-61, 2009